Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TNF Pharmaceuticals Q2 EPS $(0.18) Up From $(4.54) YoY

Author: Benzinga Newsdesk | August 19, 2025 05:54pm
TNF Pharmaceuticals (NASDAQ:TNFA) reported quarterly losses of $(0.18) per share. This is a 96.04 percent increase over losses of $(4.54) per share from the same period last year.

Posted In: TNFA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist